Juvena Therapeutics

Redwood City, CA · Founded 2017 · Privately Held (backing)

Developer of a biopharmaceutical drug discovery platform intended to discover novel protein-based therapeutics. Juvena Therapeutics is based in Redwood City, CA and was founded in 2017. Its last reported valuation was $100 million in Nov 2022. It has raised $132 million across 2 recorded rounds; the latest was a $30.5 million early-stage round in Jun 2025.

Last reported valuation
$100.0M
Oct 2026
Priced at
—
Total raised
$132.2M
Last round
Early Stage VC
Jun 2025
What is Juvena Therapeutics worth?
$100.0Mlast reported valuation · Oct 2026

Juvena Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.

Free account
More of Juvena Therapeutics with a free account
  • ·The complete investor list: 34 names
  • ·Watch Juvena Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Juvena Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Jun 2025Early Stage VC$30.5M▮
Feb 2018Seed Round$4.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Juvena Therapeutics valuation

Juvena Therapeutics's last reported valuation was $100 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Juvena Therapeutics raised?

Juvena Therapeutics has raised $132 million in total; 2 of its rounds are on record. The largest on record was a $4.3 million seed round in Feb 2018; the most recent was a $30.5 million early-stage round in Jun 2025.

Juvena Therapeutics has filed 2 Form Ds with the SEC since 2018, most recently in Jul 2025 ($30.5 million sold to 12 investors).

How Juvena Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Juvena Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Juvena Therapeutics

What is Juvena Therapeutics worth?
Juvena Therapeutics is valued at $100.0M as of Oct 2026. Juvena Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.
How much has Juvena Therapeutics raised?
Juvena Therapeutics has raised $132.2M in total funding across 2 recorded rounds.
When did Juvena Therapeutics last raise?
Juvena Therapeutics last raised in Jun 2025 (Early Stage VC), raising $30.5M.